JO3448B1 - استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العين - Google Patents
استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العينInfo
- Publication number
- JO3448B1 JO3448B1 JOP/2006/0102A JOP20060102A JO3448B1 JO 3448 B1 JO3448 B1 JO 3448B1 JO P20060102 A JOP20060102 A JO P20060102A JO 3448 B1 JO3448 B1 JO 3448B1
- Authority
- JO
- Jordan
- Prior art keywords
- azithromycin
- manufacture
- treatment
- ocular infections
- medicament intended
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
يهدف الاختراع الحالي الى تطبيق طريقة تحضير دواء طبي يستند على قاعدة اساسها مادة الازيتروميسين( azithromycine) لعلاج الالتهابات البصرية للعينين، ويتكون هذا العلاج بشكل اساسي من مادة الازيتروميسين ( azithromycine) على شكل محلول داخل ناقل( موجه) مقبول على المستوى الصيدلي يتكون من مادة ثلاثي غليسيريدات ( triglycerides) الحوامض الدهنية المصمم استنادا على سلسة متوسطة من التكثيف بنسبة من 1 الى 2% للاستعمال لمدة مرتين في اليوم الواحد موضعيا في كل عين خلال مدة تقل عن اربعه ايام.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504069A FR2884716B1 (fr) | 2005-04-22 | 2005-04-22 | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3448B1 true JO3448B1 (ar) | 2020-07-05 |
Family
ID=35445697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2006/0102A JO3448B1 (ar) | 2005-04-22 | 2006-04-16 | استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العين |
Country Status (25)
Country | Link |
---|---|
US (2) | US20060252711A1 (ar) |
EP (1) | EP1877066A1 (ar) |
JP (1) | JP2008536908A (ar) |
KR (1) | KR20080008377A (ar) |
CN (1) | CN101163486B (ar) |
AR (1) | AR053591A1 (ar) |
AU (1) | AU2006238595A1 (ar) |
BR (1) | BRPI0608375A2 (ar) |
CA (1) | CA2603833A1 (ar) |
EA (1) | EA200702295A1 (ar) |
FR (1) | FR2884716B1 (ar) |
HK (1) | HK1119064A1 (ar) |
IL (1) | IL186092A (ar) |
JO (1) | JO3448B1 (ar) |
MA (1) | MA29467B1 (ar) |
MX (1) | MX2007013054A (ar) |
MY (1) | MY169533A (ar) |
NO (1) | NO20075943L (ar) |
PE (1) | PE20070157A1 (ar) |
SG (1) | SG164382A1 (ar) |
TN (1) | TNSN07370A1 (ar) |
TW (1) | TWI430799B (ar) |
UA (1) | UA94708C2 (ar) |
WO (1) | WO2006111844A1 (ar) |
ZA (1) | ZA200709872B (ar) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2098219A1 (en) | 2008-03-05 | 2009-09-09 | PARI Pharma GmbH | Macrolide compositions having improved taste and stability |
US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Smt有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100489759B1 (ko) * | 1996-12-09 | 2005-05-16 | 바슈 앤드 롬 인코포레이티드 | 일회용 가요성 컨테이너 |
US6861411B1 (en) * | 1997-12-02 | 2005-03-01 | Pfizer, Inc. | Method of treating eye infections with azithromycin |
DK0925789T4 (da) * | 1997-12-02 | 2009-07-13 | Pfizer Prod Inc | Anvendelse af azithromycin ved topisk behandling af öjeninfektioner |
US7056893B2 (en) * | 1999-03-31 | 2006-06-06 | Insite Vision, Inc. | Topical treatment for prevention of ocular infections |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
FR2823441B1 (fr) * | 2001-04-12 | 2004-09-10 | Thea Lab | Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation |
-
2005
- 2005-04-22 FR FR0504069A patent/FR2884716B1/fr active Active
-
2006
- 2006-04-16 JO JOP/2006/0102A patent/JO3448B1/ar active
- 2006-04-18 TW TW095113740A patent/TWI430799B/zh active
- 2006-04-20 AR ARP060101560A patent/AR053591A1/es unknown
- 2006-04-20 PE PE2006000412A patent/PE20070157A1/es not_active Application Discontinuation
- 2006-04-20 MY MYPI20061806A patent/MY169533A/en unknown
- 2006-04-21 US US11/408,161 patent/US20060252711A1/en not_active Abandoned
- 2006-04-21 EA EA200702295A patent/EA200702295A1/ru unknown
- 2006-04-21 JP JP2008507188A patent/JP2008536908A/ja active Pending
- 2006-04-21 KR KR1020077027244A patent/KR20080008377A/ko not_active Application Discontinuation
- 2006-04-21 WO PCT/IB2006/000963 patent/WO2006111844A1/fr active Application Filing
- 2006-04-21 EP EP06744536A patent/EP1877066A1/fr not_active Ceased
- 2006-04-21 CN CN2006800135229A patent/CN101163486B/zh active Active
- 2006-04-21 MX MX2007013054A patent/MX2007013054A/es not_active Application Discontinuation
- 2006-04-21 AU AU2006238595A patent/AU2006238595A1/en not_active Abandoned
- 2006-04-21 UA UAA200713028A patent/UA94708C2/ru unknown
- 2006-04-21 SG SG201005298-3A patent/SG164382A1/en unknown
- 2006-04-21 BR BRPI0608375-7A patent/BRPI0608375A2/pt not_active Application Discontinuation
- 2006-04-21 CA CA002603833A patent/CA2603833A1/fr not_active Abandoned
-
2007
- 2007-09-20 IL IL186092A patent/IL186092A/en active IP Right Grant
- 2007-10-01 TN TNP2007000370A patent/TNSN07370A1/fr unknown
- 2007-11-15 ZA ZA200709872A patent/ZA200709872B/xx unknown
- 2007-11-19 NO NO20075943A patent/NO20075943L/no not_active Application Discontinuation
- 2007-11-21 MA MA30395A patent/MA29467B1/fr unknown
-
2008
- 2008-09-30 HK HK08110973.2A patent/HK1119064A1/xx unknown
-
2009
- 2009-09-08 US US12/555,509 patent/US20100069315A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2884716B1 (fr) | 2009-08-21 |
EP1877066A1 (fr) | 2008-01-16 |
JP2008536908A (ja) | 2008-09-11 |
MY169533A (en) | 2019-04-22 |
CN101163486B (zh) | 2011-11-30 |
IL186092A0 (en) | 2008-01-20 |
TNSN07370A1 (fr) | 2009-03-17 |
IL186092A (en) | 2016-05-31 |
TW200716142A (en) | 2007-05-01 |
US20100069315A1 (en) | 2010-03-18 |
CN101163486A (zh) | 2008-04-16 |
WO2006111844A1 (fr) | 2006-10-26 |
ZA200709872B (en) | 2008-09-25 |
BRPI0608375A2 (pt) | 2010-08-31 |
AU2006238595A1 (en) | 2006-10-26 |
MA29467B1 (fr) | 2008-05-02 |
EA200702295A1 (ru) | 2008-04-28 |
UA94708C2 (ru) | 2011-06-10 |
PE20070157A1 (es) | 2007-03-09 |
NO20075943L (no) | 2008-01-15 |
FR2884716A1 (fr) | 2006-10-27 |
TWI430799B (zh) | 2014-03-21 |
AR053591A1 (es) | 2007-05-09 |
SG164382A1 (en) | 2010-09-29 |
HK1119064A1 (en) | 2009-02-27 |
KR20080008377A (ko) | 2008-01-23 |
US20060252711A1 (en) | 2006-11-09 |
CA2603833A1 (fr) | 2006-10-26 |
MX2007013054A (es) | 2008-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012163A (es) | Hetarilanilinas como moduladores para beta-amiloide. | |
TW200639159A (en) | Treatment of pain | |
NZ610068A (en) | Compositions comprising povidone-iodine | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
WO2007085018A3 (en) | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution | |
HK1124546A1 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
EP3069720A8 (en) | Pharmaceutical composition containing glutarimide derivatives, and application thereof for treating eosinophilic diseases | |
MX366496B (es) | Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso. | |
GB2456475A (en) | Composition for the treatment of skin conditions | |
TW200505880A (en) | Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals | |
JO3448B1 (ar) | استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العين | |
WO2005123651A8 (en) | L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF | |
UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
BR112013020195A2 (pt) | composições farmacêuticas livres de citrato compreendendo anakinra | |
BRPI0602179A (pt) | composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação | |
SI1596879T1 (sl) | Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice | |
WO2007144889A3 (en) | Treatment of neurofibromatosis | |
TW200833347A (en) | Method of treating mucin deficiency with an active pharmaceutical and related composition | |
MY167609A (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
WO2006076119A3 (en) | Treatment of skin diseases | |
MX2007012991A (es) | Formas solidas cristalinas y amorfas de halofenato (-) y metodoss relacionados a las mismas. | |
MX2009002254A (es) | Dosis de bifeprunox para tratar esquizofrenia. | |
BRPI0417797A (pt) | soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos |